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Abstract
The transcription factor Pax6 is a crucial regulator of eye and central nervous system development. Both the
spatiotemporal patterns and the precise levels of Pax6 expression are subject to tight control, mediated by an
extensive set of cis-regulatory elements. Previous studies have shown that a YAC reporter transgene containing
420Kb of genomic DNA spanning the human PAX6 locus drives expression of a tau-tagged GFP reporter in mice in a
pattern that closely resembles that of endogenous Pax6. Here we have closely compared the pattern of tau-GFP
reporter expression at the cellular level in the forebrains and eyes of transgenic mice carrying either complete or
truncated versions of the YAC reporter transgene with endogenous Pax6 expression and found several areas where
expression of tau-GFP and Pax6 diverge. Some discrepancies are due to differences between the intracellular
localization or perdurance of tau-GFP and Pax6 proteins, while others are likely to be a consequence of
transcriptional differences. We show that cis-regulatory elements that lie outside the 420kb fragment of PAX6 are
required for correct expression around the pallial-subpallial boundary, in the amygdala and the prethalamus. Further,
we found that the YAC reporter transgene effectively labels cells that contribute to the lateral cortical stream,
including cells that arise from the pallium and subpallium, and therefore represents a useful tool for studying lateral
cortical stream migration.
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Introduction
Pax6 encodes a highly evolutionarily conserved transcription
factor with two DNA-binding domains - a paired domain and a
paired-type homeodomain [1,2]. Small eye (Sey) mutant mice
heterozygous for a loss-of-function allele of Pax6 have
defective eye development while Pax6-/- homozygotes die
around the time of birth with multiple defects of the eyes and
brain. Humans who are heterozygous for mutations in PAX6
suffer from congenital aniridia and brain defects while
homozygous mutations in PAX6 are incompatible with life [3-9].
Pax6 is expressed in the eye, pancreas and several regions of
the nervous system including the forebrain [7,10-14]. In the
forebrain, Pax6 is expressed in a complex and dynamic
pattern, including a clear gradient of expression across the
developing cerebral cortex. Graded Pax6 levels across the
embryonic neocortex are essential for the correct specification
of cortical areas and for maintaining their progenitor cell
proliferation rates [15-20]. Interestingly, both downregulation
and overexpression of Pax6 in mice cause defects of the eye
and brain [15-17,20,21]. Thus, tight control of Pax6’s complex
spatiotemporal expression pattern is essential for normal
development.
A number of previous studies have examined mechanisms
involved in the transcriptional control of Pax6. Several short-
range cis-regulatory elements have been identified 5’ and 3’ of
the Pax6 transcript unit and in its introns and have been
characterized using reporter assays in transgenic mice
[9,22-29]. Notably, some of these regulatory elements exhibit
overlapping tissue specificity, particularly in the eye and
diencephalon, suggesting that they have cooperative functions.
Although these short-range regulatory elements account for
much of the endogenous Pax6 expression pattern in mice,
genetic analyses from humans and mice revealed that they are
insufficient to drive the full pattern of Pax6 expression,
particularly in the eye and brain [27,30,31]. Evidence for the
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presence of distant regulatory elements downstream of human
PAX6 came from genetic analyses of patients with congenital
aniridia, some of whom have chromosomal rearrangements
whose breakpoints are far downstream of the PAX6
transcriptional unit [32-36], suggesting that the rearrangement
has separated distal regulatory elements from the body of the
PAX6 gene, leading to defective PAX6 expression. The most
distant breakpoint of these aniridia-related chromosomal
rearrangements, designated “SIMO” (Figure 1A), is located 124
kb downstream from the PAX6 polyadenylation site [32,34].
The importance of this distant region was reinforced by the
finding that a 420 kb yeast artificial chromosome (YAC) Y593
(Figure 1A) comprising the human PAX6 coding sequence and
200 kb flanking genomic regions on either side, stretching
beyond the SIMO breakpoint, rescues the eye phenotype of
small eye (Sey) mice, whereas a shorter YAC transgene Y589
(Figure 1A) containing 110 kb less of Y593’s DNA sequence
(30 kb at the 5’ end and 80 kb at the 3’ end ) does not [34].
Further detailed analyses through genomic sequence
comparison and DNaseI hypersensitivity mapping suggested
the presence of regulatory elements within the PAX6
downstream regulatory region (DRR) extending over 75 kb
mainly 3’ to the SIMO breakpoint (Figure 1A) [21,31,34]. These
elements are located within introns of the adjacent, ubiquitously
expressed gene ELP4 and are thought to be crucial for the
induction of PAX6 expression in eye and diencephalon
[27,28,30,31,37].
Previous work aimed at gaining a better insight into the
functions of distant regulatory elements in governing Pax6
expression generated a series of novel YAC transgenic
reporter mice, carrying either full length 420 kb YAC 593 or
truncated YAC transgenes in which a tau-GFP reporter
cassette replaces the first coding PAX6 exon, preventing the
production of functional full-length PAX6 from the transgenes.
In these transgenic lines, the GFP reporter cassette is inserted
at the PAX6 translational start site in exon 4 (Figure 1B). GFP
expression is, therefore, under the control of those PAX6
regulatory elements contained within the YAC transgene and is
independent of the endogenous mouse Pax6 locus [30,31,38].
Previous analyses of these lines did not examine the detailed
expression patterns of the transgenes in sub-regions of the eye
and brain. Here, we carried out such an analysis since
relatively subtle deviations from normal patterns of endogenous
Pax6 expression are likely to provide further useful insights into
Pax6 regulation and to be important for those using these
transgenic alleles as tools to mark specific populations of cells.
Materials and Methods
Ethics statement
The licence authorising this work was approved by the
University of Edinburgh's Ethical Review Committee on 22nd
September 2008 (application number PL35-08) and by the
Home Office on 6th November 2008. Animal husbandry was in
accordance with the UK Animals (Scientific Procedures) Act
1986 regulations. To minimise animal suffering, pregnant dams
were culled by cervical dislocation under terminal anaesthesia
according to the Code of Practice for Humane Killing of
Figure 1.  Summary of YAC transgenic mouse lines.  (A)
Schematic map of human chromosome 11p13 showing the
locations of the PAX6 and ELP4 loci, which are in an antisense
orientation relative to each other. The locations of PAX6
promoters (P0, P1, Pa and P4) are indicated by black arrows.
PAX6 and ELP4 exons are shown as open rectangles. The
breakpoints of the two distal-most aniridia-associated
rearrangements are indicated by “SGL” and “SIMO”. Red
circles indicate some known PAX6 regulatory elements. The
location of the downstream regulatory region (DRR) is shown
by red arrows. The schematic maps of YACs Y593 (420 kb)
and Y589 (310 kb) are indicated. In transgenic mice, Y593, but
not Y589, rescues the mouse Sey phenotype and homozygous
Sey lethality. (B) Schematic map of YAC transgenes in different
YAC transgenic mouse lines. Construct pDT-1 contained
sequences expressing tau-GFP and conferring neomycin (neo)
resistance, separated by an internal ribosomal entry site
(IRES), terminated with polyadenylation and C2MAZ (pAC2m)
sequences and flanked by 5' and 3' homology regions (5'HR
and 3'HR). Homologous recombination resulted in the
introduction of this construct at the translation initiation site
(ATG) in exon 4 of the human PAX6 locus, to produce the YAC
Y1123.. The PAX6 transcription unit is indicated by a blue box
into which a tau-GFP-IRES-Neomycin cassette, indicated by
green box, was inserted. The known hypersensitive sites (HS
sites) within the DRR region are shown by red arrows. The
position of LoxP sites are indicated by orange triangles. The
highly conserved cis-regulatory elements E60, E100 and RB
are indicated by purple ellipses. Line DTy54 contains a single-
copy of YAC 1123. Line Y223 carries 6 copies of YAC 374 in
which a pair of LoxP sites flank a 35 kb genomic region within
the DRR. Line Y001 contains a single copy of the truncated
YAC 374 lacking the distal-most 20 kb sequences including the
known RB enhancer. Line Y001ΔDRR is directly derived from
Y001 line by Cre-mediated deletion of the 35 kb DRR region.
All YACs have the same sequences at the 5’ end.
doi: 10.1371/journal.pone.0080208.g001
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Animals under Schedule 1 to the Animals (Scientific
Procedures) Act 1986 issued by the Home Office.
Mice
Mice were bred in accordance with the UK Animals
(Scientific Procedures) Act 1986 regulations. YAC transgenic
mouse lines DTy54, Y223, Y001 and Y001ΔDRR were
hemizygous for the tau-GFP reporter YAC transgene and were
maintained on a CD1 background. Transgenic animals were
identified by PCR for the reporter transgene as described
previously [38] and embryos were genotyped by detecting GFP
fluorescence.
Immunofluorescence
Following deparafinization in xylene, sections were
rehydrated through a descending ethanol series and washed in
PBS. Antigen retrieval was carried out by microwaving sections
in 0.01M sodium citrate (pH6.0) for 20 minutes. Sections were
washed with PBS-0.01% Triton X-100 and then incubated for
30 minutes in blocking solution containing 20% goat or donkey
serum, then incubated overnight at 4°C with primary antibodies
diluted in blocking solution. Primary antibodies used in this
study were rabbit anti-GFP (Abcam 1:100), mouse anti-Pax6
(DSHB 1:100), rabbit anti-Tbr1 (Abcam 1:100), rabbit anti-Tbr2
(Abcam 1:100), rabbit anti-Gsh2 (gift from Kenneth Campbell
1:1500). Following incubation with primary antibodies, sections
were washed in PBS-0.01% Triton X-100 and incubated with
secondary antibodies for 1 hour at room temperature. For
fluorescent staining, secondary antibodies used were donkey
anti-mouse Alexa Fluor 488 or 568 as well as donkey anti-
rabbit Alexa Fluor 488 or 568. Nuclei were counterstained with
TOPRO-3 (Molecular Probes, 1:1000). Fluorescent images
were captured using a Leica NTS confocal microscope.
In situ hybridization
In situ hybridization was performed using the standard
protocol [39]. Sense and antisense digoxigenin-labeled RNA
probes were generated from a BamHI digest of the pCR-Blunt
II-TOPO Pax6 cDNA clone and a Kpn1 digest of the
pBluescript II KS+ GFP cDNA clone using a DIG RNA labeling
kit (Roche). Sections were dewaxed and rehydrated through
xylene and graded alcohols, washed in PBS and digested in
20µg/ml Proteinase K in PBS at 37°C for 5 minutes. Sections
were then washed first in 0.2% Glycine/PBS and then in PBS,
and post-fixed in 4% PFA/0.2% glutaraldehyde for 20 minutes.
Sections were washed again in PBS before incubation with
prehyb solution for two hours and were then hybridized
overnight with 1ng/µl probe in prehyb solution. Following
hybridization sections were rinsed in 2xSSC, pH4.5 and then
washed at 5°C below the hybridization temperature in 50%
Formamide/2xSSC. Sections were then washed in PBS/
Tween0.1%, incubated for 1 hour at room temperature in
Boehringer blocking solution containing 10% sheep serum
followed by incubation at 37°C with anti-DIG for 2 hours.
Sections were washed overnight in PBS/Tween0.1%, and finally
washed in NTM and stained with NBT/BCIP.
Results
Detailed comparison of tau-GFP reporter and
endogenous Pax6 expression in the forebrain of DTy54
transgenic mice
DTy54 transgenic mice carry a single copy of YAC 1123,
which is a full-length version of YAC 593 modified so that it
expresses tau-tagged GFP instead of PAX6 (summarized in
the upper part of Figure 1B) [38]. To compare expression of the
tau-GFP reporter and endogenous Pax6, coronal sections
along the rostral–caudal axis were double-immunolabeled for
tau-GFP and Pax6 protein. Whereas staining for Pax6 is
nuclear, tau-GFP binds to the microtubule component of the
cytoskeleton and labels the cytoplasm [38,40].
In DTy54 embryos, tau-GFP was seen in regions of the
telencephalon known to express Pax6. The expression level of
tau-GFP in the cerebral cortex was graded from high laterally
to low medially at all rostral-caudal levels and was generally
higher rostrally (Figure 2B,E,H), in agreement with the gradient
of Pax6 expression (Figure 2A,D,G). However, the coincidence
between tau-GFP and Pax6 expression broke down in the
subpallium. Whereas there was a step down in the level of
Pax6 expression from cortex to LGE at the pallial-subpallial
border (PSPB), high levels of tau-GFP extended across the
PSPB into the LGE (Figure 2A-I). Pax6 and tau-GFP were
expressed in cells migrating ventrally away from the PSPB
region along the putative lateral cortical stream (LCS) towards
the developing basolateral telencephalon, but the expression
domain of tau-GFP in this region was broader than that of
Pax6, particularly caudally (Figure 2A,B,D,E,G,H). The
expression level of tau-GFP relative to its levels in other tau-
GFP-expressing regions was higher than that of Pax6 relative
to its levels in other Pax6-expressing regions. We also
observed a discrepancy between tau-GFP and Pax6
expression in the amygdaloid area, where a population of Pax6
expressing cells close to the pial surface did not express tau-
GFP (Figure 2J).
In the diencephalon, tau-GFP expression mirrored quite
closely that of Pax6, with high levels of both in the pretectum,
low levels of both in the thalamus and high levels of both in the
prethalamus (Figure 2A-C). In the prethalamus, Pax6+ and tau-
GFP+ cells were located through the depth of the
neuroepithelium from the ventricular surface to the pial surface,
with a large amount of tau-GFP on the pial side (Figure 2K). In
addition, as in the amygdaloid area, we observed a small patch
of ventrally-located Pax6+ cells that were negative for tau-GFP
(Figure 2K)
In general, a lack of coincidence between tau-GFP and Pax6
proteins might stem from the differences in their subcellular
localization. Pax6+ progenitors in the anterior neural tube have
radial processes that span the overlying neuroepithelium.
These processes would accumulate tau-GFP but not Pax6
protein. Another factor might be a longer perdurance of tau-
GFP protein than Pax6 protein in postmitotic cells that have
migrated into the mantle zone from the underlying proliferative
zone. These factors could account for tau-GFP staining
overlying the Pax6+ progenitors in the cortex and diencephalon
(Figure 2K,L). However, neither is likely to explain the
Genomic Regions Regulating Pax6 Expression
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Figure 2.  Expression of Pax6 and tau-GFP in DTy54 embryonic forebrain at E12.5.  Double immunofluorescence for Pax6
(red) and GFP (green) on coronal sections taken along the rostrocaudal axis. (A, D, G) In the telencephalon, Pax6 is expressed in
the ventricular zone of the cortex (CTX), in the VZ of LGE with very low levels, in a stream of cells migrating towards the basal
ventral telencephalon, and in the amygdaloid area (AMY). In the diencephalon, Pax6 is broadly expressed in the pretectum (PT) and
prethalamus (PTH) with high expression levels, and in the midline of the thalamus (TH) with relatively low levels. (B, E, H) tau-GFP
is expressed in all Pax6 expressing regions. (C, F, I) Direct comparison of tau-GFP and Pax6 expression revealed that tau-GFP
expression replicates the known Pax6 pattern with some exceptions. (J) Pax6 single expressing cells are present within the
amygdaloid region (arrows). (K) A band of Pax6 only expressing cells is located adjacent to the tau-GFP labeled cellular processes
in the prethalamus (arrows). (L) tau-GFP labeled radial glial processes extend into the mantle region of the cortex. LCS, lateral
cortical stream; PSPB, pallial subpallial boundary; LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence. n=10
DTy54 embryos. Scale bars: A-I, 200µm; J-L, 100 µm.
doi: 10.1371/journal.pone.0080208.g002
Genomic Regions Regulating Pax6 Expression
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unusually high levels of tau-GFP in a broad region of the
ventricular zone of the LGE and in postmitotic cells in and
around the LCS, given the very low levels of Pax6 protein in
the ventricular zone of the LGE and the relative sparseness of
Pax6+ cells in the LCS (Figure 2A-I).
Comparison of tau-GFP and Pax6 mRNA expression
suggests that some regulatory elements are missing
from YAC1123
As described above, the very high levels of tau-GFP in the
subpallium (Figure 2B,E,H) are associated with ventricular
zone progenitors, their radial process and the postmitotic
derivatives of those progenitors, which express either very low
or undetectable levels of Pax6. Discrepancies between the
patterns of tau-GFP and Pax6 protein expression in the
subpallium of DTy54 embryos might arise as a result of
differences in transcription from the transgene and the
endogenous Pax6 locus. To address this possibility, we carried
out in situ hybridizations for tau-GFP and Pax6 in adjacent
sections of E12.5 DTy54 forebrain at all rostral–caudal levels.
In the cortex, both transcripts were expressed in the ventricular
zone with levels that were graded from high laterally to low
medially (Figure 3A-F). But while Pax6 mRNA levels dropped
sharply at the PSPB, levels of tau-GFP mRNA did not (Figure 3
G-I), mirroring the discrepancy between the Pax6 and tau-GFP
protein expression patterns in this region. In addition, whereas
Pax6 mRNA was expressed in postmitotic cells in the
basolateral telencephalon (Figure 3G,I), as was Pax6 protein
(Figure 2J), tau-GFP mRNA was undetectable in these cells
(Figure 3H,I), as was tau-GFP protein (Figure 2J). These
results indicate that the discrepancy between the Pax6 and
tau-GFP protein expression patterns in the subpallium can be
accounted for by difference in transcription between the YAC
1123 transgene and the endogenous Pax6 locus in this region.
This analysis also showed that tau-GFP mRNA was not
expressed by cells in the LCS (Figure 3H), unlike tau-GFP
protein expression which was present along the whole LCS
(Figure 2 B,E,H). The presence of tau-GFP protein along the
LCS is likely explained by its being in the radial processes of
progenitor cells around the PSPB (which are known to form a
palisade at this boundary that defines the route of the LCS
[41,42]) and perdurance of tau-GFP protein in migrating
derivatives of these progenitors.
Analysis of tau-GFP in the LCS in DTy54 transgenic
mice
Expression of tau-GFP protein in the LCS of DTy54 embryos
was correlated with the expression of other LCS markers using
double-immunostaining. Many Pax6/ tau-GFP co-expressing
cells were observed on the pallial side of the PSPB at E12.5
and E15.5 (Figure 4). Very few tau-GFP+ cells on the subpallial
side of the PSPB expressed Pax6 at E12.5 (Figure 4 A,B).
Slightly more of them expressed Pax6 at E15.5, but most did
not (Figure 4 C,D). The pallial marker Tbr2 is expressed in
basal progenitor cells located in the pallial subventricular zone
[43-45] whereas Tbr1, another pallial marker, is expressed in
post-mitotic neurons in the mantle layers and migrating along
the LCS to contribute excitatory neurons to the amygdala
Figure 3.  In situ hybridization for Pax6 and Tau-GFP on
coronal sections of E12.5 DTy54 embryos.  Adjacent 10μm
coronal sections were hybridized with a probe for Pax6
(A,C,E,G) or tau-GFP (B,D,F,H). (A-H) Pax6 and tau-GFP
expression throughout caudal to rostral levels of the forebrain.
(G-I) Direct comparison of Pax6 and tau-GFP transcripts in the
ventral telencephalon. Image in G is colour-inverted and
superimposed on that in H to produce the merged image in I.
Arrow indicates the PSPB. Strong tau-GFP expression was
expanded into the subpallial side of the PSPB, while Pax6
expression levels dropped sharply at the PSPB. In addition,
only Pax6 mRNA but not tau-GFP mRNA was expressed in the
postmitotic cells in the basolateral telencephalon (asterisk in
G). LCS, lateral cortical stream. n=8 DTy54 embryos. Scale
bars: 200µm.
doi: 10.1371/journal.pone.0080208.g003
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[46-48]. At E12.5 and E15.5, most of the strongly labelled tau-
GFP+ cells that lay immediately beneath the ventricular zone of
the LGE expressed neither Tbr2 nor Tbr1 (Figure 5). By E15.5,
the LCS comprised a mixture of cells that expressed both tau-
GFP and Tbr1+ (presumably pallial-derived) or tau-GFP only
(presumably subpallial-derived) (Figure 5H). Gsh2 is a
subpallial marker expressed by progenitors of the LGE and
neurons migrating from this region along the LCS to become
excitatory neurons in the amygdala [41,49-51]. At E12.5, the
heavily labeled tau-GFP+ subpallial cells lay beneath the
Gsh2+ domain in the ventricular zone of the subpallium (Figure
6 A,B). At E15.5, a stream of Gsh2+ cells was present within
the tau-GFP labeled LCS (Figure 6 C,D). These Gsh2+ cells
ran through the centre of the LCS, dividing it into a ventral part
expressing high levels of tau-GFP and a dorsal part expressing
lower levels of tau-GFP (Figure 6D).
These results indicate that the tau-GFP labeled LCS
comprises a mixture of cell types, some derived from
progenitors on the subpallial side of the PSPB and others from
progenitors on the pallial side, subsets of which express Pax6,
Tbr2, Tbr1 or Gsh2. Tau-GFP expression in DTy54 mice is a
good marker of cells entering and migrating through the LCS.
The particularly strong expression of tau-GFP along the LCS
on the ventral side of the PSPB is likely to be due to a
combination of perdurance of tau-GFP protein and ectopic
transcription of the reporter YAC. Such ectopic transcription of
the transgene could be due to the absence of one or more
transcriptional repressive element(s) from the YAC, or an effect
of the transgene integration site.
Analysis of tau-GFP reporter expression in the
forebrain of other PAX6 YAC reporter transgenics
To assess whether the integration site of the YAC transgene
contributed to the discrepancy between Pax6 and tau-GFP
expression in the DTy54 subpallium, we examined tau-GFP
reporter expression in additional YAC transgenic lines. The
transgenic line Y223 carries six copies of YAC Y374, which is
slightly modified from YAC Y1123 by the insertion of two loxP
sites [30](Figure 1B). Tau-GFP is expressed at particularly high
levels in this transgenic line, most likely due to the higher copy
number, but its pattern is otherwise identical to that in DTy54
mice (Figure 7), suggesting that neither the copy number, nor
the genomic insertion site nor the presence of the loxP sites
affects expression as compared to that of Y1123 (the YAC
carried in line DTy54). The same discrepancy between the tau-
GFP and the Pax6 expression in the subpallium was observed
in this line as in DTy54 mice, indicating that the discrepancy is
not due to the insertion site and is most likely due to the
Figure 4.  Pax6 is expressed in a subpopulation of tau-GFP heavily labeled LCS in DTy54 transgenic mouse line at both
E12.5 and E15.5.  (A) Pax6 is expressed in the tau-GFP labeled LCS cells at E12.5 (arrows). (B) Higher magnification of boxed
area in A revealed that at the ventricular zone of the PSPB, tau-GFP heavily expressing cells are located adjacent to the Pax6
positive cell populations, along with a small subset of cells expressing both tau-GFP and Pax6 (arrows). (C) Pax6 is expressed in
the tau-GFP labeled LCS cells at E15.5 (arrows). (D) Higher magnification of boxed area in C further revealed that a subset of tau-
GFP labeled LCS cells also express Pax6 (arrows). n=10 DTy54 embryos.
doi: 10.1371/journal.pone.0080208.g004
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Figure 5.  Some tau-GFP labelled LCS cells co-express Tbr2 and Tbr1 in DTy54 transgenic mice.  (A) Tbr2 and tau-GFP
expression at E12.5. (B) Higher magnification of boxed area in A revealing that Tbr2 positive cells are juxtaposed to the most
strongly tau-GFP labeled cells. (C) Tbr2 and tau-GFP expression at E15.5. (D) Higher magnification of boxed area in C further
revealed that a subset of tau-GFP labeled LCS cells also expressed Tbr2 (arrows). (E) Tbr1 is not expressed in the tau-GFP labeled
LCS cells at E12.5. (F) Higher magnification of boxed area in E revealed that Tbr1 positive cells are distinct to the tau-GFP strongly
labeled LCS cells. (G) A subset of tau-GFP labeled LCS cells co-expressed Tbr1 at E15.5 (arrows). (H) Higher magnification of
boxed area in G further revealed that a subset of tau-GFP labeled LCS cells, which seem to arise from the mantle region of the
pallium, co-expresses Tbr1 (arrows). n=10 DTy54 embryos.
doi: 10.1371/journal.pone.0080208.g005
Genomic Regions Regulating Pax6 Expression
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absence from the YAC of repressive elements required to
silence Pax6 transcription in the subpallium.
We then examined expression of tau-GFP in lines carrying
truncated versions of Y374. Line Y001 carries a single copy of
YAC 374 lacking approximately 20kb from its distal
downstream end, lost during integration of the transgene
[30,31] (Figure 1B). In the Y001 telencephalon, tau-GFP
expression exhibits only a partial Pax6 expression pattern. In
the cortex, the levels of tau-GFP expression appear much
lower than those of Pax6 (Figure 8 A-I, L). In the Y001
diencephalon, tau-GFP expression is maintained in the
prethalamus, but lost from the pretectum and the thalamus
(Figure 8 A-F,J,K). These findings suggest that the missing
distal 20kb contains cis-regulatory elements required for
transgene expression in the cortex, thalamus and pretectum. In
the Y001 subpallium, the same discrepancy between the tau-
GFP and the Pax6 expression was observed as in DTy54 mice
(Figure 8 D-I,M-O).
Transgenic mouse line Y001ΔDRR was generated
previously from line Y001 by cre-mediated deletion of the 35 kb
DRR, and therefore has the same genomic integration site [30]
(Figure 1B). Expression of the transgene was very similar to
that in Y001: levels of transgene expression were very low in
the cortex, pretectum and thalamus, although contrary to
previous conclusions [30] there was diencephalic expression in
the prethalamus, as in Y001 (Figure 9 A-L). Some of the
strongest tau-GFP expression was in the subpallium, where the
same discrepancy between tau-GFP and Pax6 expression was
observed as in DTy54 mice (Figure 9D-I,M-O).
In summary, these results indicate that elements distal to
DRR are required for the expression of Pax6 in the cortex,
thalamus and pretectum. Elements beyond even the full-length
Y1123 are needed for correct regulation of Pax6 in the
subpallium, involving repression in cells entering the LCS and
expression in cells exiting it.
Tau-GFP reporter expression in the eyes of the YAC
transgenic lines
Pax6 is expressed dynamically during early development of
the mouse eye, in both the surface ectoderm and the optic
vesicle, which integrate to generate the eye [10,52-54]. At
E12.5, Pax6 is widely expressed in the presumptive cornea,
retinal pigmented epithelium, neural retina and lens (Figure 10
A,D,G,J). In both DTy54 and Y223 lines, tau-GFP and Pax6
expression coincided and retinal ganglion cell axons were
labeled with tau-GFP in the optic nerve (Figure 10 B,C,E,F). In
Figure 6.  Gsh2 is expressed in a subpopulation of tau-GFP heavily labeled LCS cells in DTy54 transgenic mouse line at
both E12.5 and E15.5.  (A) The tau-GFP heavily labeled cell populations overlapped the Gsh2 positive domain in the VZ of the
subpallium at E12.5. (B) Higher magnification of boxed area in A revealed that a subset of tau-GFP labeled LCS cells co-expressed
Gsh2 (e.g. arrows). (C) A stream of Gsh2 expressing cells are present within the tau-GFP labeled LCS at E15.5. (D) Higher
magnification of boxed area in C further revealed that a subset of tau-GFP labeled LCS cells co-expresses Gsh2 (e.g. arrows). n=10
DTy54 embryos.
doi: 10.1371/journal.pone.0080208.g006
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Figure 7.  Double immunostaining for Pax6 and tau-GFP on coronal sections at caudal to rostral levels through the
forebrain from E12.5 Y223 embryos.  (A, D, G) Pax6 expression pattern is reflected by red fluorescence. (B, E, H) Tau-GFP is
expressed in all Pax6 expressing regions. Tau-GFP heavy labeling of cellular processes can be seen in both the telencephalon and
the diencephalon. (C, F, I) Direct comparison of tau-GFP and Pax6 expression revealed that tau-GFP expression replicates the
known Pax6 pattern with some exceptions. (J) Pax6 and tau-GFP protein are co-localized in the pretectum (PT). (K) A group of cells
only expressing Pax6 and not tau-GFP is intermingled with the tau-GFP labeled cellular processes in the prethalamus. (L) tau-GFP
labeled radial glial processes extend into the mantle region of the cortex. (M) tau-GFP highly labeled cells are present on the
subpallial side of the PSPB. (N) A subset of tau-GFP labeled migratory cells co-expresses Pax6. (O) Pax6 single expressing cells
are present within the amygdaloid (AMY) region. Abbreviations as in Figure 2. n=10 Y223 embryos. Scale bars: A-C, 200µm; D-O,
100 µm.
doi: 10.1371/journal.pone.0080208.g007
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Figure 8.  Double immunostaining for Pax6 and tau-GFP on coronal sections at caudal to rostral levels through the
forebrain from E12.5 Y001 embryos.  (A, D, G) Pax6 expression is reflected by red fluorescence. (B, E, H) In the diencephalon,
tau-GFP is only expressed in the prethalamus (PTH). The tau-GFP expression in the cortex is dramatically reduced in comparison
with the endogenous Pax6 expression. tau-GFP highly labeled cells are present in the ventral telencephalon, (C, F, I) Direct
comparison of tau-GFP and Pax6 expression revealed that tau-GFP expression only exhibits a partial Pax6 pattern, with some
notable discrepancies. (J) tau-GFP expression in the pretectum (PT) is lost. (K) A band of Pax6 only expressing cell is located
adjacent to the tau-GFP labeled cellular processes in the prethalamus. (L) The expression of tau-GFP in the cortex (CTX) is very
weak. (M) tau-GFP heavily labeled cells are present in the mantle region of the ventral telencephalon. (N) A subset of tau-GFP
labeled migratory cells co-expresses Pax6. (O) Pax6 single expressing cells are present within the amygdaloid (AMY) region.
Abbreviations as in Figure 2. n=8 Y001 embryos Scale bars: A-I, 200µm; J-O, 100 µm.
doi: 10.1371/journal.pone.0080208.g008
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Figure 9.  Double immunostaining for Pax6 and tau-GFP on coronal sections at caudal to rostral levels through the
forebrain from E12.5 Y001ΔDRR embryos.  (A, D, G) Pax6 expression is reflected by red fluorescence. (B, E, H) In the
diencephalon, tau-GFP is only expressed in the prethalamus. The tau-GFP expression in the cortex is dramatically reduced in
comparison with the endogenous Pax6 expression. tau-GFP highly labeled cells are present in the ventral telencephalon. (C, F, I)
Direct comparison of tau-GFP and Pax6 expression revealed that tau-GFP expression only exhibits a partial Pax6 pattern, with
some notable discrepancies. (J) Tau-GFP expression in the pretectum (PT) and the thalamus is lost. (K) tau-GFP expression in the
prethalamus (PTH) is weak compared with the endogenous Pax6 expression. Tau-GFP labeling of cellular processes still can be
clearly seen. (L) The expression of tau-GFP in the cortex (CTX) is very weak. (M) tau-GFP heavily labeled cells are present in the
mantle region of the ventral telencephalon. (N) A subset of tau-GFP labeled migratory cells co-expresses Pax6. (O) Pax6 single
expressing cells are present within the amygdaloid (AMY) region. Abbreviations as in Figure 2. n=8 Y001ΔDRR embryos. Scale
bars: A-I, 200µm; J-O, 100 µm.
doi: 10.1371/journal.pone.0080208.g009
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the Y001 line tau-GFP expression was maintained in most of
these tissues (presumptive cornea, retinal pigmented
epithelium, lens), but its level was reduced in many retinal cells
(Figure 10 H,I). Only retinal ganglion cells that expressed the
highest levels of Pax6 continued to express tau-GFP in this
line, suggesting the existence of essential enhancer elements
within the missing distal end of this YAC transgene that are
required for full transgene expression in the retina. Deletion of
the DRR in line Y001ΔDRR completely abolished transgene
expression in all regions of the eye, consistent with previous
observations and confirming the functional significance of the
DRR in control of Pax6 expression in the eye (Figure 10 K, L)
[27,30].
Discussion
The functional importance of the precise control of
spatiotemporal levels of Pax6 expression during embryonic
development is well established. A number of evolutionarily
conserved regulatory elements (CEs) in the PAX6 locus have
been described previously [25,27,30,35,55] and the finding that
a YAC transgene containing a 420 kb region of the human
PAX6 locus rescued the mouse small eye (Sey) phenotype
indicated that most of PAX6’s cis-acting regulatory elements
are contained in this region [21]. Our new findings (i) indicate
that at least one important element, which regulates Pax6
expression in the LCS, lies outside this region and (ii) ascribe
to a region within the 20kb downstream of the DRR a function
in promoting high levels of cortical, pretectal and thalamic
expression.
Analysis of tau-GFP reporter expression in YAC
transgenic lines
We found that tau-GFP reporter expression in the forebrain
and eye of two transgenic lines (DTy54 and Y223) carrying full-
length reporter YAC transgenes derived from Y593 largely
resembled that of Pax6, in agreement with previous studies
[30,38]. However, close examination of tau-GFP and
endogenous Pax6 expression at the cellular level highlighted
some interesting differences. Some differences are most likely
a consequence of the different intracellular locations of tau-
GFP (cytoskeletal) and Pax6 (nuclear) proteins while others
are likely due to differences between the half-lives of tau-GFP
and Pax6 proteins. Other differences however, appear to be
due to differences in the transcriptional regulation between the
YAC transgenes and the endogenous Pax6 locus. This is the
most likely explanation for the presence of cells within the
subpallial VZ that express very high levels of tau-GFP mRNA
but only very low or no detectable Pax6 mRNA. Pax6
expression in this area is normally repressed by Gsh2 [41,56].
Therefore, one attractive possibility is that the Y1123 transgene
may lack crucial repressor elements responsive to factors,
possibly including Gsh2, that normally inhibit Pax6 transcription
in this region [56,57]. Differences between Pax6 and tau-GFP
mRNA expression were also found in the amygdaloid area and
the prethalamus, where small groups of cells were seen to
express Pax6 mRNA, but not tau-GFP mRNA. All expression
differences between tau-GFP and PAX6 mRNA in the
subpallial VZ, amygdaloid area and prethalamus were found in
two separate transgenic strains containing almost identical
regions of the PAX6 locus, but integrated at different genomic
positions, suggesting that the expression differences are due to
the absence of cis-regulatory elements in the YAC DNA, rather
than effects of the integration site on transgene expression
(position effects).
Examination of further transgenic lines, carrying truncated
versions of Y374, confirmed the presence of essential
regulatory elements at the distal end of the YAC. The YAC
reporter transgene in line Y001, lacking the distal-most 20kb of
YAC374, is expressed in the cortex (albeit at lower levels) and
in the prethalamus, but not in the thalamus, consistent with
previous reports [30,31], nor in the pretectum. The deleted
20kb region contains a highly conserved element, termed RB,
which is able to drive expression of a reporter transgene in the
diencephalon and the dorsal telencephalon [30]. It is interesting
to note that although a previous study found that tau-GFP was
widely expressed in the retina of Y001 embryos at E17.5 [30],
here we found that many retinal ganglion cells in Y001
embryos did not express tau-GFP at E12.5, suggesting that
unidentified regulatory elements within the very distal end of
the YAC 374 are required for the temporal control of Pax6
expression in the retina.
In YAC transgenic line Y001ΔDRR, the 35 kb DRR present
in line Y001 was deleted by cre-mediated recombination.
Expression of the transgene was very similar to that in line
Y001 in the telencephalon and diencephalon but was
completely lost in the eye, indicating the functional importance
of this genomic region in driving expression in the eye. A
previous study indicated that the DRR is required for regulation
of Pax6 expression in both the eye and diencephalon [30].
However, in the present study, detailed comparison between
transgene and Pax6 expression provided novel evidence that
unknown regulatory elements distal to DRR are more critical to
drive expression in the diencephalon, since the loss of DRR in
line Y001ΔDRR did not result in significant changes in
transgene expression in the diencephalon.
It is important to note that several eye and diencephalic
regulatory elements have been characterized upstream of the
DRR, including two lens enhancers located 5’ to Pax6 Palpha
and P4 promoters [22,24,58], a diencephalic enhancer located
between Pax6 P0 and P1 promoters [22,26], a CE2 element
within intron seven required for expression in both the eye and
the diencephalon [25,28], and highly conserved elements E60
and E100 located downstream from Pax6 exon 13 that drive
expression in the diencephalon and retina [28]. The absence of
tau-GFP expression in subregions of the eye and diencephalon
in both Y001 and Y001ΔDRR lines suggests that unidentified
regulatory elements within the distal-most 20kb of the YAC 374
are not redundant for the full Pax6 expression patterns in those
regions of the brain. It is likely that full Pax6 expression in the
eye and diencephalon requires the actions of multiple cis-
regulatory elements widely placed within the Pax6 locus. In
order to drive Pax6 expression, there might be a requirement
for the activity of the regulatory elements within the very distal
end of the full-length YAC transgene in coordination with other
elements to drive overlapping expression patterns. At present,
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however, it is still unclear how exactly these cis-regulatory
elements coordinate to control Pax6 expression. Further study
using directed mutations or deletions of specific enhancer
elements in the intact YAC transgene or the endogenous Pax6
locus will improve the understanding of their synergistic
actions.
Tau-GFP as a marker for the lateral cortical stream in
Dty54 transgenic mice
The migratory cells of the lateral cortical stream (LCS) are
derived from progenitors in the VZ of the PSPB and migrate
ventrally towards the amygdaloid region where they contribute
to the developing amygdala [47,50,59,60]. The LCS contains
Figure 10.  Double immunostaining for Pax6 and tau-GFP on coronal sections through the eye from E12.5 embryos of YAC
transgenic mouse lines.  (A, D, G, J) Pax6 is expressed in retinal pigmented epithelium (rpe), neural retina (nr) and lens. (B, C) In
the DTy54 line, tau-GFP expression replicates the Pax6 pattern in all tissues of the eye. (E, F) In the Y223 line, tau-GFP expression
matches Pax6 expression pattern in all eye tissues. (H, I) In the Y001 line, tau-GFP expression is restricted in the retina and is only
present in some retinal ganglion cells (RGCs) that strongly express Pax6. (K, L) In the Y001ΔDRR line, Cre-mediated deletion of the
DRR completely abolishes tau-GFP expression in the eye. (B, E, H) tau-GFP labeling of the axonal projections of RGCs can be
seen in the optic nerve (on). n>8 YAC transgenic embryos per line. Scale bars: 100µm.
doi: 10.1371/journal.pone.0080208.g010
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cells derived from both the pallium (Pax6+ and Tbr1+) and the
subpallium (Dlx2+ and Gsh2+) [47,50,59]. Tau-GFP labels a
set of Pax6-expressing cells which appear to be migrating
towards the basolateral telencephalon of our PAX6 YAC
transgenic lines at both E12.5 and E15.5. Based on their
location and expression of Pax6, Tbr1 and Gsh2, these almost
certainly belong to the LCS. At E12.5, most of the tau-GFP
labeled migrating cells were derived from the subpallial side of
the PSPB. However, by E15.5, when migration of the LCS is
most pronounced, tau-GFP labelled a broader population of
migrating cells which comprised cells from both the pallium and
subpallium, indicating that the cellular composition of the tau-
GFP labeled LCS is dynamic. Our finding that tau-GFP labels
multiple subsets of LCS cells during development
demonstrates that these YAC transgenic strains may prove to
be useful tools to visualize LCS migration defects in mutant
mice.
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